Volume Alert - ARCP 8.88 American Realty Capital Propert

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - ARCP 8.88 American Realty Capital Propert $ARCP Hit a high today of 8.93 Closing the day 10:30 at 8.88 +0.09 +1.02% With a day low of 8.75 and a total volume of 1,983,179.

ARCP Recent Posts: http://investorshangout.com/American-Realty-C...RCP-53359/

ARCP American Realty Capital Propert Recent Headline News

RCS Capital (RCAP) Stock Plummeting After Cole Capital Lawsuit
at The Street - 58 mins ago
RCS Capital (RCAP) stock is sinking this morning as the company is being sued by American Realty Capital Properties for allegedly backing out of a deal for Cole Capital.
RCAP: 10.10 (-1.49), ARCP: 8.82 (+0.03)

ARCP Options Send Bullish Signal On Wednesday
Orange Peel Investments - at Seeking Alpha - 2 hrs 54 mins ago

ARCP: 8.82 (+0.03)

7 MoPay SML Divi-Dogs Pitch 41% To 83% Early November Upsides
Fredrik Arnold - at Seeking Alpha - Wed Nov 12, 2:48PM CST

AT: 2.12 (-0.03), ERF: 14.75 (-0.65), BTE: 27.59 (-1.03), QRE: 14.87 (-0.40), AGNC: 22.67 (+0.15), BBEP: 15.16 (-0.54), ROYT: 9.84 (-0.04), NDRO: 8.81 (-0.05), ARP: 15.73 (-0.08), LNCO: 20.50 (-0.30), FSC: 8.79 (-0.03), ARR: 3.94 (-0.06), CPG: 31.23 (-0.91), PGH: 3.77 (-0.16), ARCP: 8.82 (+0.03), LINE: 22.66 (-0.57), PSEC: 9.70 (+0.01)

American Realty Capital: The Nick Schorsch REIT Empire Is Crumbling
Albert Alfonso - at Seeking Alpha - Wed Nov 12, 11:37AM CST

RCAP: 10.11 (-1.48), ARCP: 8.82 (+0.03)

13 Stocks With Dividend Yields Over 10%
Dividend Yield - at Seeking Alpha - Wed Nov 12, 9:28AM CST
I know you like dividends and can't wait to receive the next payment from your favorite company. Dividends are great, but most of the dividend stocks don't give you high amounts of cash into your pocket. Why don't we look for stocks with very high...
DCT: 8.40 (unch), NLY: 11.36 (+0.03), LNCO: 20.50 (-0.30), CIM: 3.25 (+0.01), TWO: 10.27 (+0.02), AGNC: 22.67 (+0.15), BBEP: 15.17 (-0.53), NTI: 25.21 (-0.16), ARCP: 8.82 (+0.03), LINE: 22.66 (-0.57), WIN: 9.80 (+0.11), PSEC: 9.70 (+0.01), VNR: 24.80 (-0.11)

Realty Income: Don't Reach For This Yield Play
Reuben Gregg Brewer - at Seeking Alpha - Wed Nov 12, 6:50AM CST

O: 46.45 (+0.11), ARCP: 8.82 (+0.03)

American Realty sues RCS Capital
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 5:48AM CST

RCAP: 10.11 (-1.48), ARCP: 8.82 (+0.03)

American Realty Capital Properties Comments on Litigation it Filed Against RCS Capital Corporation
PR Newswire - Wed Nov 12, 5:00AM CST
American Realty Capital Properties, Inc. ("ARCP" (NASDAQ: ARCP) issued the following statement regarding litigation it filed yesterday in the Court of Chancery of the State of Delaware against RCS Capital Corporation ("RCS" (NYSE: RCAP) in connection with RCAP's purported termination of the equity purchase agreement, dated September 30, 2014, between RCS and an affiliate of ARCP (the "Purchase Agreement" :
RCAP: 10.11 (-1.48), ARCP: 8.82 (+0.03)

Market Maker Surveillance Report. SRC, VOD, DG, ARCP, KOG, VSAR, Bullishly Biased Price Friction For Tuesday, November 11th 2014
M2 - Wed Nov 12, 3:24AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4865 companies with "abnormal" market making, 2315 companies with positive Friction Factors and 2446 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Sierra Pacific Resources Pies (NYSE:SRC), Vodafone Group PLC (NASDAQ:VOD), Dollar General Corp (NYSE G), American Realty Capital Properties Inc (NASDAQ:ARCP), Kodiak Oil & Gas Corp (NYSE:KOG), (NASDAQ:VSAR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
KOG: 9.66 (-0.28), VSAR: 19.35 (-0.18), DG: 65.01 (+0.11), ARCP: 8.82 (+0.03), VOD: 35.28 (-0.06), SRC: 11.53 (-0.04)

Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.35 (-0.37), ACHN: 13.96 (-0.89), DNDN: 0.14 (-0.02), CMCSK: 54.08 (+0.68), ARCP: 8.82 (+0.03), ZNGA: 2.80 (-0.01), MSFT: 49.38 (+0.60), INTC: 33.60 (+0.22), GRPN: 7.86 (-0.24), CMCSA: 54.33 (+0.73), AAPL: 113.01 (+1.76), CSCO: 25.67 (+0.56)

The Securities Arbitration Law Firm of Klayman & Toskes Investigates The Sale of American Realty Capital Properties by FINRA Broker-Dealers
Business Wire - Tue Nov 11, 4:10PM CST
The Securities Arbitration Law Firm of Klayman & Toskes, P.A. ("K&T" (www.nasd-law.com) announced today that it is investigating the sale of American Realty Capital Properties (NasdaqGS: ARCP) ("American Realty" by FINRA broker-dealers. American Realty is a real estate investment trust ("REIT" . Specifically, K&T is investigating the level of due diligence performed by FINRA broker-dealers who sold American Realty, and whether customer accounts were over-concentrated in American Realty. K&T's investigation comes on the heels of American Realty's announcement that accounting errors were "intentionally" made in the amount of about $23 million. Since trading at about $12.50 at the end of October, American Realty has plummeted 32% and is currently trading at about $8.60 per share. American Realty had been trading as high as $14.88 per share in March of this year, representing an eight month decline of about 43%.
ARCP: 8.82 (+0.03)

Realty Income: Strong Portfolio Growth History Makes This REIT A Cornerstone Income Investment
Achilles Research - at Seeking Alpha - Tue Nov 11, 2:55PM CST

O: 46.45 (+0.11), ARCP: 8.82 (+0.03)

Report: Nearly 40K reps and advisers stop selling Schorsch non-traded REITs
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:22AM CST

RCAP: 10.13 (-1.46), ARCP: 8.82 (+0.03)

American Realty Capital Properties: A Buy Even Though It Might Get Worse Before It Gets Better
Reuben Gregg Brewer - at Seeking Alpha - Tue Nov 11, 1:35AM CST

ARCP: 8.82 (+0.03)

ARCP: Friday's Commentary Helps Bull Case
Orange Peel Investments - at Seeking Alpha - Mon Nov 10, 6:19PM CST

ARCP: 8.82 (+0.03)

Why I Doubled My Position In American Realty Capital Properties Last Week
The Owl - Seeking Alpha - Sun Nov 09, 1:19PM CST
Full Disclosure: I hold a sizeable position in American Realty Capital Properties ( ARCP ). Background: It is not news to investors who follow ARCP that there has been a considerable amount of concern about the value of ARCP, following...
ARCP: 8.82 (+0.03)

Going Against The Grain With American Realty Capital Properties
Charles Lewis Sizemore, CFA - at Seeking Alpha - Fri Nov 07, 7:25PM CST
American Realty Capital Properties (NASDAQ: ARCP ) is a company that will give you heartburn. Since news of its accounting scandal broke last week, it’s lost nearly 40% of its value. But these are precisely the kinds of situations that...
ARCP: 8.82 (+0.03)

Upcoming Investor Conferences, Survey Results, Corporate Statement, and Third Quarter Results - Research Reports on Visa, Simon, Goldman Sachs, ARCP and Umpqua
PR Newswire - Fri Nov 07, 8:20AM CST
Today, Analysts Review released its research reports regarding Visa Inc. (NYSE: V), Simon Property Group Inc. (NYSE: SPG), The Goldman Sachs Group, Inc. (NYSE: GS), American Realty Capital Properties, Inc. (NASDAQ: ARCP) and Umpqua Holdings Corporation (NASDAQ: UMPQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7793-100free.
UMPQ: 17.69 (-0.15), RCAP: 10.13 (-1.46), GS: 189.95 (-0.23), V: 250.94 (-1.01), SPG: 179.10 (+0.78), ARCP: 8.82 (+0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 185

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Opportunities in Oversold Tech Stocks Today

Updated Category News Views 121

Market Dynamics and Oversold Stocks Recently, we witnessed a notable sell-off in the stock market, which was fueled by rising concerns surrounding the AI industry. As a result, many stocks experienced a significant pullback. Interestingly, this downturn did not discriminate and impacted various equities, including those unrelated to the AI sector. It's essential to...

Continue Reading
Innovative Device Revolutionizes Leg Recovery Process

Updated Category News Views 109

A Breakthrough in Leg Recovery: The LEG LIFTER Recovering from an injury or surgery can be a challenging process, especially when it comes to managing mobility. An inventive entrepreneur has come up with a unique solution to assist those dealing with leg injuries. The designer, based in Marietta, has developed the LEG LIFTER, a tool aimed at facilitating the lifting and...

Continue Reading
Vizsla Silver's New Strategic Acquisition Enhances Panuco Project

Updated Category News Views 78

Vizsla Silver Expands its Footprint with Key Acquisition In an exciting development, Vizsla Silver Corp. (NYSE: VZLA) (TSX: VZLA) has entered into an agreement to acquire significant claims that will bolster its already promising Panuco project. Ten new claims totaling 2,378 hectares have been purchased from Minera Fresnillo S.A. de C.V., a Fresnillo plc subsidiary. This...

Continue Reading
C3.ai Investors Seek Justice Amid Recent Stock Concerns

Updated Category News Views 91

Understanding the Situation for C3.ai Investors C3.ai, Inc. (NYSE: AI) has recently made headlines, not for positive advancements, but due to significant concerns regarding its stock performance and allegations of misleading statements. Shareholders who purchased shares during a specific class period might have encountered substantial losses, prompting the need for...

Continue Reading
Class Action Alert for Investors of Regeneron Pharmaceuticals

Updated Category News Views 139

Investors of Regeneron Pharmaceuticals Urged to Act In the bustling world of biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has captured significant attention. Recently, the exceptionally reputable Rosen Law Firm announced a class action lawsuit, bringing notice to shareholders who have purchased securities from November 2, 2023, to October 30, 2024. This...

Continue Reading